BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12459556)

  • 1. Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor alpha, the tyrosine phosphatase SHP-1, and the proteasome.
    Hanson EM; Dickensheets H; Qu CK; Donnelly RP; Keegan AD
    J Biol Chem; 2003 Feb; 278(6):3903-11. PubMed ID: 12459556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
    Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
    J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
    Paling NR; Welham MJ
    Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction.
    Haque SJ; Harbor P; Tabrizi M; Yi T; Williams BR
    J Biol Chem; 1998 Dec; 273(51):33893-6. PubMed ID: 9852037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
    Shen X; Tian Z; Holtzman MJ; Gao B
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
    Wheadon H; Edmead C; Welham MJ
    Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis.
    Wang HY; Zamorano J; Keegan AD
    J Biol Chem; 1998 Apr; 273(16):9898-905. PubMed ID: 9545332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor.
    Huang Z; Xin J; Coleman J; Huang H
    J Immunol; 2005 Feb; 174(3):1332-7. PubMed ID: 15661890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
    Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
    Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells.
    White ED; Andrews RP; Hershey GK
    J Leukoc Biol; 2001 May; 69(5):825-30. PubMed ID: 11358992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase activity is required for IL-4 induction of IL-4 receptor alpha-chain.
    Huang H; Paul WE
    J Immunol; 2000 Feb; 164(3):1211-5. PubMed ID: 10640732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHP-1 regulates STAT6 phosphorylation and IL-4-mediated function in a cell type-specific manner.
    Huang Z; Coleman JM; Su Y; Mann M; Ryan J; Shultz LD; Huang H
    Cytokine; 2005 Feb; 29(3):118-24. PubMed ID: 15613279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation.
    Yu CL; Jin YJ; Burakoff SJ
    J Biol Chem; 2000 Jan; 275(1):599-604. PubMed ID: 10617656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunits.
    Moriggl R; Erhardt I; Kammer W; Berchtold S; Schnarr B; Lischke A; Groner B; Friedrich K
    Eur J Biochem; 1998 Jan; 251(1-2):25-35. PubMed ID: 9492265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei.
    Wu TR; Hong YK; Wang XD; Ling MY; Dragoi AM; Chung AS; Campbell AG; Han ZY; Feng GS; Chin YE
    J Biol Chem; 2002 Dec; 277(49):47572-80. PubMed ID: 12270932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.
    Nguyen VA; Chen J; Hong F; Ishac EJ; Gao B
    Biochem J; 2000 Jul; 349(Pt 2):427-34. PubMed ID: 10880341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear phosphatases and the proteasome in suppression of STAT1 activity in hepatocytes.
    Liu D; Scafidi J; Prada AE; Zahedi K; Davis AE
    Biochem Biophys Res Commun; 2002 Dec; 299(4):574-80. PubMed ID: 12459177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.